Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06414993 · ClinicalTrials.gov registry record · NA
Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults
A NA study of Polysubstance Drug Use (Indiscriminate Drug Use), sponsored by Chestnut Health Systems.
- Recruiting
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 8
- Study locations
NCT06414993: Recruiting NA study of Polysubstance Drug Use (Indiscriminate Drug Use), sponsored by Chestnut Health Systems.
NCT06414993 is a NA study of Polysubstance Drug Use (Indiscriminate Drug Use) that is actively recruiting participants, run by Chestnut Health Systems. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 8 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06414993, a NA study of Polysubstance Drug Use (Indiscriminate Drug Use), is actively recruiting participants, sponsored by Chestnut Health Systems.
- RECRUITING
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 8
- Study locations
Study Summary
Emerging adults (EAs; aged 18-26) are the highest-risk population for poly-substance use (misuse of more than one drug), compared to all other age groups and are the least-served population for substance use services. The overarching purpose of this pilot study is to assess whether an innovative services package, Launch, can reasonably work (is feasible) and whether providers and participants like it (acceptability). Launch works with both EAs and a supportive parent (or parental figure) and delivers peer recovery support services (PRSS) to EAs while helping parents use an effective, evidence-based program called contingency management, adapted for EAs, at home with their EA child. This study will also lay the groundwork for a future large-scale trial of Launch services.
Primary Outcome
Levels of acceptability of the Launch intervention, such as if participants like the intervention, as reported by emerging adults on the Acceptability of Intervention Measure. Scores range from 4-20. Higher scores indicate higher levels of intervention acceptability.
Conditions Studied
Interventions
- BEHAVIORAL Contingency Management for Emerging Adults (CM-EA)
- BEHAVIORAL Standard Peer Recovery Support Services (PRSS) +Vocational/Educational (V/E) Skill Building services
Study Locations (8)
Illinois
- A New Horizon - Bloomington
- Chestnut Health Systems - Granite City
- Take Action Today - West Frankfort
Georgia
- Rising Sun Recovery - Hiram
Indiana
- Wabash Valley Recovery Center - Terre Haute
Missouri
- Chestnut Health Systems - Hillsboro
Oregon
- Chestnut Health Systems - Eugene
Tennessee
- WeCare Hawkins - Rogersville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2024-06-07 |
| Est. Completion | 2026-09-01 |
| Phase | NA |
What NCT06414993 shows while recruiting
NCT06414993 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 1 condition, with Polysubstance Drug Use (Indiscriminate Drug Use) appearing as the primary indexed condition, and to 2 interventions - of which Contingency Management for Emerging Adults (CM-EA) is the first listed.
NCT06414993 lists 8 locations in 6 states (Illinois, Georgia, Indiana).
Frequently Asked Questions
What is clinical trial NCT06414993 about?
NCT06414993 is a clinical study titled "Leveraging Parents and Peers to Increase Recovery Capital in Emerging Adults". Emerging adults (EAs; aged 18-26) are the highest-risk population for poly-substance use (misuse of more than one drug), compared to all other age groups and are the least-served population for substance use services. The overarching purpose of this pilot study is to assess whether an innovative ser...
What is the current status of trial NCT06414993?
This trial is currently recruiting. It is a NA study. The enrollment target is 48 participants. The study started on 2024-06-07. Estimated completion is 2026-09-01.
What conditions does trial NCT06414993 study?
This clinical trial studies the following conditions: Polysubstance Drug Use (Indiscriminate Drug Use).
What interventions are being tested in trial NCT06414993?
The interventions under investigation include: Contingency Management for Emerging Adults (CM-EA) (BEHAVIORAL), Standard Peer Recovery Support Services (PRSS) +Vocational/Educational (V/E) Skill Building services (BEHAVIORAL).
Who is sponsoring clinical trial NCT06414993?
This trial is sponsored by Chestnut Health Systems, which has 20 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06414993 being conducted?
This trial has 8 study locations across Georgia, Illinois, Indiana, Missouri, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polysubstance Drug Use (Indiscriminate Drug Use)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06414993's enrollment target sits among peer trials
48 1381st of 2000 higher than 601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01765777 · 48 participants · NA
Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain
- NCT03073343 · 48 participants · NA
A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine
- NCT03431064 · 48 participants
Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients
- NCT03514602 · 48 participants · NA
Maternal Smoking Cessation and Pediatric Obesity Prevention
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI